Excellent 4.6 out of 5
Respiratory and Allergic Disorders

Gallstones

Gallstones can block bile flow, stressing the liver and bile ducts. Biomarker testing tracks this cholestasis. At Superpower, we test ALP, GGT, and Bilirubin Direct for Gallstones to detect bile duct obstruction and hepatobiliary injury (cholestatic pattern) early.

With Superpower, you have access to a comprehensive range of biomarker tests.

Test for Gallstones
Cancel anytime
HSA/FSA eligible
Results in a week
Physician reviewed

Every result is checked

·
CLIA-certified labs

Federal standard for testing

·
HIPAA compliant

Your data is 100% secure

Key Benefits

  • Check for bile duct blockage caused by gallstones.
  • Flag bile backup when ALP, GGT, and direct bilirubin rise together.
  • Explain jaundice or dark urine by confirming bile flow obstruction on labs.
  • Guide urgency and imaging if levels suggest a common bile duct stone.
  • Clarify whether a high ALP is liver-related using GGT confirmation.
  • Protect your pancreas by flagging obstruction that can trigger gallstone pancreatitis.
  • Track recovery after a passed stone or after gallbladder treatment.
  • Best interpreted with AST, ALT, total bilirubin, ultrasound, and your symptoms.

What are Gallstones

Gallstone biomarkers are blood signals that reveal how stones are disturbing bile flow, stressing the liver, or involving nearby organs. When a stone irritates or blocks a bile duct, liver pigments and enzymes leak into circulation: bilirubin (conjugated bilirubin), bile duct–linked enzymes (alkaline phosphatase, gamma‑glutamyl transferase), and liver cell enzymes (alanine aminotransferase, aspartate aminotransferase). If a stone obstructs the outlet where the bile duct meets the pancreas, pancreatic enzymes rise (amylase, lipase). The body’s immune response to irritation or infection can also increase general inflammation markers (white blood cell count, C‑reactive protein). Taken together, these biomarkers show the site and impact of the problem—whether it is confined to the gallbladder, causing duct blockage (cholestasis), triggering infection in the bile ducts (cholangitis), or involving the pancreas (gallstone pancreatitis). Testing them helps translate hidden pressure and tissue injury into a clear picture of severity and urgency, guiding the need for imaging and timely treatment even before the stones are directly seen.

Why are Gallstones biomarkers important?

Gallstones biomarkers are the lab signals that reveal how well bile moves from the liver through the gallbladder into the intestine. Because bile carries cholesterol and bilirubin and enables fat and fat‑soluble vitamin absorption, these markers reflect not just gallbladder health but liver function, pancreatic safety, nutrient handling, and the body’s systems for clearing waste pigments.

In practice, cholestatic enzymes (ALP and GGT) and conjugated pigment (direct bilirubin) are most telling. Typical adult reference ranges are roughly ALP 40–120, GGT 10–40, and direct bilirubin under 0.3. For most adults, “optimal” tends to be the lower half of the range for ALP and GGT, and near-zero for direct bilirubin. When a stone blocks bile flow, ALP and GGT rise—often more than liver transaminases—and direct bilirubin climbs, bringing dark urine, pale stools, itching, jaundice, and right‑upper‑quadrant pain. Mild isolated GGT elevation can reflect enzyme induction (alcohol, certain drugs), so the pattern across tests matters.

When these values are low or low‑normal—especially undetectable direct bilirubin—it usually means bile is flowing freely, gallstones (if present) are not obstructing, and symptoms are unlikely. Very low ALP is uncommon and usually reflects nonbiliary issues (such as hypophosphatasia or severe deficiency states). Children and teens normally have higher ALP from bone growth; pregnancy raises ALP via the placenta while GGT often stays low; women are more prone to gallstones, but normal biomarkers suggest no duct blockage.

Big picture: these markers integrate liver excretion, gallbladder motility, pancreatic duct safety, lipid transport, and hemoglobin breakdown. Persistently abnormal patterns point to risks like cholangitis, pancreatitis, or secondary biliary injury, while healthy values support efficient digestion, vitamin absorption, and metabolic resilience over time.

What Insights Will I Get?

Gallstones matter because they can block bile flow, which is central to fat digestion, absorption of fat‑soluble vitamins, cholesterol transport, detoxification, and gut–liver immune signaling. Disrupted bile movement (cholestasis) can ripple into energy balance, metabolic health, and inflammation. At Superpower, we test ALP, GGT, and Direct (conjugated) Bilirubin to read this bile-flow circuit.

ALP is an enzyme concentrated in bile duct cells (also in bone and placenta). GGT is a liver and bile duct enzyme that tracks more specifically with biliary stress. Direct Bilirubin is the liver‑processed form of bilirubin that should exit via bile; it rises when conjugated bilirubin cannot drain because of obstruction. Gallstones that obstruct ducts typically elevate ALP and GGT and can raise Direct Bilirubin.

For stability, a normal trio suggests unobstructed bile flow and resilient biliary epithelium. Concordant increases in ALP and GGT point to a biliary source of injury, supporting a cholestatic pattern consistent with stone-related blockage. An isolated ALP rise invites caution because bone or placental sources can contribute. Elevation of Direct Bilirubin indicates impaired excretion of conjugated bilirubin, often reflecting more substantial or sustained obstruction. Fluctuating results may mirror intermittent stone passage; persistent abnormalities suggest ongoing cholestasis.

Notes: ALP is higher in pregnancy and adolescence and with bone disorders. GGT can be induced by alcohol and certain medications. Sepsis and other illnesses can cause cholestasis. Gilbert syndrome and hemolysis affect indirect (not direct) bilirubin. Timing, recent illness, and assay differences influence values.

Superpower also tests for

See more diseases

Frequently Asked Questions About Gallstones

What is Gallstones testing?

Gallstone biomarker testing looks for signs that bile flow is blocked or slowed. When gallstones obstruct the bile ducts, bile backs up and spills into blood. Superpower tests for ALP, GGT, and Direct (conjugated) Bilirubin. Elevated ALP and GGT point to bile duct stress or blockage (cholestasis). A rise in Direct Bilirubin signals impaired excretion of conjugated bile pigment. These markers do not “see” stones, but they flag the physiologic impact of obstruction and help separate biliary problems from other liver or bone conditions.

Why should I get Gallstones biomarker testing?

It tells you if your bile ducts are under pressure from a blockage. A cholestatic pattern (high ALP and GGT with elevated Direct Bilirubin) supports gallstone obstruction rather than muscle, bone, or purely hepatocellular injury. These labs also help gauge severity, detect complications like cholangitis or pancreatitis risk, and track resolution once the stone passes or is removed. Superpower’s ALP, GGT, and Direct Bilirubin focus on the physiology of bile flow, not just symptoms.

How often should I test?

There is no fixed schedule. Test during symptoms suggestive of biliary obstruction and to establish a baseline. Repeat to confirm resolution after an acute episode or an intervention. If results are abnormal, follow-up testing documents the trend (worsening, stable, improving). Routine screening in people without symptoms is not useful, because these markers reflect current bile duct stress, not long-term risk. Frequency should reflect the clinical course and whether obstruction is suspected or resolving.

What can affect biomarker levels?

Alcohol use can raise GGT even without obstruction. Pregnancy and bone growth/disorders raise ALP from bone sources; pairing ALP with GGT helps confirm a biliary origin. Certain drugs (e.g., estrogen-containing therapies, some antibiotics, anticonvulsants, anabolic steroids) can cause cholestatic patterns or induce GGT. Hemolysis and inherited Gilbert syndrome raise unconjugated (indirect) bilirubin, not Direct Bilirubin. Recent fasting can nudge bilirubin up. Severe illness, sepsis, or infiltrative liver disease can elevate ALP. Lab sample hemolysis can artifactually alter bilirubin.

Are there any preparations needed before Gallstones biomarker testing?

No special prep is required for ALP, GGT, or Direct Bilirubin. Fasting is not necessary. Avoid alcohol in the prior 24 hours if possible, as it can raise GGT and blur interpretation. Tell the lab about recent new medications or supplements, since some can shift cholestatic enzymes. Hydrate normally. If you’ve had recent imaging contrast or an acute illness, timing relative to symptoms can influence results; testing during symptoms best captures obstruction physiology.

Can lifestyle changes affect my biomarker levels?

Yes, but within limits. Alcohol intake strongly influences GGT. Prolonged fasting can increase bilirubin slightly. However, when gallstones block bile flow, ALP, GGT, and Direct Bilirubin mainly reflect the obstruction, not day-to-day habits. Once the blockage resolves, these markers typically normalize over days to weeks. Long-term lifestyle patterns can change gallstone risk, but the biomarkers themselves are acute signals of cholestasis rather than wellness metrics.

How do I interpret my results?

A cholestatic pattern—high ALP and GGT with elevated Direct Bilirubin—supports bile duct obstruction from gallstones. High ALP with normal GGT suggests a non-hepatic (often bone) source. Isolated GGT elevation is nonspecific and often alcohol or medication induced. Predominantly indirect (unconjugated) bilirubin points away from obstruction. Normal values do not rule out intermittent obstruction; timing matters. Biomarkers show bile flow physiology; imaging (e.g., ultrasound) confirms stones and location. Superpower reports ALP, GGT, and Direct Bilirubin to map this pattern clearly.

How do I interpret my results?

A cholestatic pattern—high ALP and GGT with elevated Direct Bilirubin—supports bile duct obstruction from gallstones. High ALP with normal GGT suggests a non-hepatic (often bone) source. Isolated GGT elevation is nonspecific and often alcohol or medication induced. Predominantly indirect (unconjugated) bilirubin points away from obstruction. Normal values do not rule out intermittent obstruction; timing matters. Biomarkers show bile flow physiology; imaging (e.g., ultrasound) confirms stones and location. Superpower reports ALP, GGT, and Direct Bilirubin to map this pattern clearly.

How it works

1

Test your whole body

Get a comprehensive blood draw at one of our 3,000+ partner labs or from the comfort of your own home.

2

An Actionable Plan

Easy to understand results & a clear action plan with tailored recommendations on diet, lifestyle changes, supplements and pharmaceuticals.

3

A Connected Ecosystem

You can book additional diagnostics, buy curated supplements for 20% off & pharmaceuticals within your Superpower dashboard.

Superpower tests more than 
100+ biomarkers & common symptoms

Developed by world-class medical professionals

Supported by the world’s top longevity clinicians and MDs.

Dr Anant Vinjamoori

Superpower Chief Longevity Officer, Harvard MD & MBA

A smiling woman wearing a white coat and stethoscope poses for a portrait.

Dr Leigh Erin Connealy

Clinician & Founder of The Centre for New Medicine

Man in a black medical scrub top smiling at the camera.

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

membership

$17

/month
Billed annually at $199
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.
A website displays a list of most ordered products including a ring, vitamin spray, and oil.
A smartphone displays health app results, showing biomarker summary, superpower score, and biological age details.A tablet screen shows a shopping website with three most ordered products: a ring, supplement, and skincare oil.
What could cost you $15,000 is $199

Superpower
Membership

Your membership includes one comprehensive blood draw each year, covering 100+ biomarkers in a single collection
One appointment, one draw for your annual panel.
100+ labs tested per year
A personalized plan that evolves with you
Get your biological age and track your health over a lifetime
$
17
/month
billed annually
Flexible payment options
Four credit card logos: HSA/FSA Eligible, American Express, Visa, and Mastercard.
Start testing
Cancel anytime
HSA/FSA eligible
Results in a week
Pricing may vary for members in New York and New Jersey **

Finally, healthcare that looks at the whole you